Therapy of pulmonary hypertension: the evolution from vasodilators to antiproliferative agents.
Rubin
Lewis J
LJ
D000818:Animals; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D004730:Endothelium, Vascular / Q000187:drug effects / Q000473:pathology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006976:Hypertension, Pulmonary / Q000188:drug therapy*; D008168:Lung / Q000098:blood supply / Q000187:drug effects / Q000473:pathology; D019821:Simvastatin / Q000627:therapeutic use; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000627:therapeutic use
D000924:Anticholesteremic Agents; D000970:Antineoplastic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D014665:Vasodilator Agents; D019821:Simvastatin